PCM
TEVA icon

Pennant Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Pennant Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-50,000
Closed -$2.64M – 49
2014
Q1 		$2.64M Sell
50,000
-80,000
-62% -$3.7M 0.04% 45
2013
Q4 		$5.21M Buy
+130,000
New +$5.12M 0.09% 45

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Pennant Capital Management's TEVA Position: Q2 2014 in Review

Pennant Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2014, closing a stake of 50,000 shares — an estimated $2.64M sold.

Pennant Capital Management first reported a position in TEVA in Q4 2013 and held it in 2 quarters. The position peaked at $5.21M in Q4 2013. 780 funds tracked by Wall St. Rank hold TEVA as of Q2 2014.

  • Pennant Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2014 after selling out during the quarter.
  • Pennant Capital Management sold 50,000 Teva Pharmaceutical Industries Limited shares in Q2 2014, an estimated $2.64M.
  • Pennant Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 2 quarters.
  • Pennant Capital Management's Teva Pharmaceutical Industries Limited position peaked at $5.21M in Q4 2013.
  • 780 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2014.

Based on Pennant Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.